Methodology

All entries for: MavriX Bio LLC

October 16, 2025

MavriX Bio LLC

Orphan Drug Designation

FDA orphan drug designation: treatment of Angelman syndrome

Disease Area: Rare Diseases
Source
Facebook Linkedin
Main Menu
Scroll to Top